Previous 10 | Next 10 |
Shares of Arcturus Therapeutics Holdings (NASDAQ: ARCT) were soaring 12.7% higher as of 3:28 p.m. EST on Tuesday. The big jump came after the clinical-stage biotech provided its third-quarter update following the market close on Monday. Investors were less interested in Arcturus' fi...
Arcturus Therapeutics ([[ARCT]] +6.0%) Q3 results:Collaboration revenue of $2.3M, compares with $3.3M last year, and misses consensus by $0.76M.Total operating expenses were $23.3M compares with $10.9M.Cash balance totaled $307.1M as of the end of Q3, compared to cash and cash equivalent...
Greenland Technologies Holding (GTEC) +88% on launching integrated electric drivetrain.Trxade Group (MEDS) +70%.Summit Wireless Technologies (WISA) +42% on Q4 guidance.Mogo (MOGO) +27% on Q3 results.Fulgent Genetics (FLGT) +16% on Q3 results.Affime...
Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2020 Results Earnings Conference Call November 09, 2020, 04:30 PM ET Company Participants Neda Safarzadeh - Head of Investor Relations, Public Relations & Marketing Joseph Payne - President & Chief Executive Officer Andy Sassine - Chief Fi...
Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2020 Earnings Conference Call November 09, 2020 4:20 PM ET Company Participants Neda Safarzadeh - Head of Investor Relations, Public Relations & Marketing Joseph Payne - President & Chief Executive Officer Steve Hughes - Chief Development ...
Arcturus Therapeutics (ARCT): Q3 GAAP EPS of -$0.92 misses by $0.44.Revenue of $2.3M (-30.7% Y/Y) misses by $0.76M.Shares +1.01%.Press Release For further details see: Arcturus Therapeutics EPS misses by $0.44, misses on revenue
Investor conference call at 4:30 p.m. ET today Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and si...
Gainers: Sundial Growers (SNDL) +79%.Aptevo Therapeutics (APVO) +60%.AMC Entertainment (AMC) +60%.Ashford Hospitality Trust (AHT) +58%.Cinemark Holdings (CNK) +56%.National CineMedia (NCMI) +48%.Tuniu (TOUR) +41%.EPR Properties (EPR) +41%.Dave & Buster's Entertainment (PLAY) +40%.Bro...
Pfizer and BioNTech's announcement that, based on preliminary data, their COVID-19 vaccine is 90% effective and an emergency use authorization ((EUA)) is only weeks away has led to downward pressure on some of the second tier developers. If all goes according to plan, deployment could start b...
The news that Pfizer and BioNTech's COVID-19 vaccine is 90% effective in preventing infection appears to be weighing on Arcturus Therapeutics Holdings (ARCT) despite positive preliminary results from a Phase 1/2 study assessing its candidate ARCT-021 in 106 young and old adult volunteers.78 s...
News, Short Squeeze, Breakout and More Instantly...
Arcturus Therapeutics Ltd. Company Name:
ARCT Stock Symbol:
NASDAQ Market:
Arcturus Therapeutics Ltd. Website:
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and medicines to treat unmet medical needs within liver and respiratory rare diseases, toda...
2024-07-02 10:15:03 ET Piper Sandler analyst issues OVERWEIGHT recommendation for ARCT on July 2, 2024 08:19AM ET. The previous analyst recommendation was Overweight. ARCT was trading at $23.66 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
ARCT-810 Phase 2 study completed enrollment at 0.3 mg/kg dose level in Europe with data expected later this year ARCT-810 to expand Phase 2 clinical program in the U.S. to enroll patients with more severe disease ARCT-032 IND for Phase 2 multiple ascending dose study to be submitt...